Inactive Instrument

Analyst Reco. OrganiGram Holdings Inc Toronto S.E.

Equities

CA68620P1018

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Organigram Brief: Says Signed Three Year Supply Agreement with Avida Medical in UK	28/05	MT
Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral	15/04	MT
Organigram Holdings Maintained at Buy at Stifel GMP Following Q2 Results; Price Target Raised to C$4.00	17/23/17	MT
Organigram Holdings Maintained at Buy at Stifel GMP After Mixed Fiscal Q2 Results; Price Target Lowered to C$1.25	13/23/13	MT
Organigram Holdings Raised to Buy at Stifel GMP Following Improved FQ1 Results; Price Target Kept at C$1.50	13/23/13	MT
Organigram Holdings Maintained at Hold at Stifel GMP Following FQ4 Results; Price Target Kept at C$1.50	29/22/29	MT
Organigram Holdings Hold Rating Maintained by Stifel GMP Following Fiscal Third-Quarter Results	15/22/15	MT
Organigram Holdings Shares Rise 4%, Upgraded to Outperform at ATB Capital	13/22/13	MT
Canaccord Genuity Upgrades OrganiGram Holdings to Speculative Buy from Hold, Adjusts Price Target to CA$3.25 from CA$3	12/22/12	MT
Organigram Holdings Price Target Raised to $3 at ATB Capital	12/22/12	MT
ORGANIGRAM : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$3.75 From C$4, Maintains Hold Rating	15/21/15	MT
ORGANIGRAM : CIBC Adjusts OrganiGram Holdings PT to C$4 From C$3.75, Maintains Neutral Rating	14/21/14	MT
ORGANIGRAM : CIBC Adjusts OrganiGram Holdings PT to C$3.75 From C$3.25, Maintains Neutral Rating	11/21/11	MT
ORGANIGRAM : CIBC Upgrades OrganiGram Holdings to Neutral from Underperform, Keeps C$3.25 Price Target	11/21/11	MT
ORGANIGRAM : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$4 From C$6, Maintains Hold Rating	15/21/15	MT
ORGANIGRAM : Raymond James Adjusts OrganiGram Holdings PT to C$5 From C$6, Maintains Outperform Rating	14/21/14	MT
ORGANIGRAM : Declines 7% As CIBC Downgrades Stock After Weak Q2 Results	14/21/14	MT
ORGANIGRAM : CIBC Downgrades OrganiGram Holdings to Underperform from Neutral, Adjusts PT to C$3.25 from C$5	14/21/14	MT
ORGANIGRAM : BMO Capital Upgrades OrganiGram Holdings to Market Perform from Underperform, Sets C$4 Price Target	08/21/08	MT
ORGANIGRAM : Raymond James Adjusts OrganiGram Holdings PT to C$6 From C$3, Maintains Outperform Rating	12/21/12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. OrganiGram Holdings Inc Toronto S.E.

Equities

CA68620P1018

Analyst Reco.

Filters